Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.19x is 35% above its 5-year average of -3.36x, near the high end of its 5-year range (-5.93x–-1.10x).
15.78% above its 12-month average of -2.60x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -3.34x.
INTEREST COVERAGE RATIO
-2.19x
INTEREST COVERAGE RATIO AVG TTM
-2.60x
INTEREST COVERAGE RATIO AVG 3Y
-2.61x
INTEREST COVERAGE RATIO AVG 5Y
-3.36x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+15.78%
CURRENT VS 3Y AVG
+16.00%
CURRENT VS 5Y AVG
+34.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
+60.47%
vs the sector median at left
NeuroPace, Inc.
Market Cap
$442.61M
Interest Coverage Ratio
-2.19x
TTM Avg
-2.60x
3Y Avg
-2.61x
5Y Avg
-3.36x
Market Cap
$444.90M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$438.13M
Interest Coverage Ratio
-16.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$449.16M
Interest Coverage Ratio
-35.51x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$434.25M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$454.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$454.47M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$425.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$461.38M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroPace, Inc. (NPCE) | $442.61M | -2.19x | -2.60x | -2.61x | -3.36x |
| Assembly Biosciences, Inc. (ASMB)vs › | $444.90M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $438.13M | -16.10x | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $449.16M | -35.51x | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $434.25M | -17.61x | 2.56x | 1.47x | 1.63x |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $454.18M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $454.47M | N/A | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $425.48M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $461.38M | 4.74x | 9.15x | 25.82x | 26.16x |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $417.95M | -404.95x | N/A | N/A | N/A |
Interest Coverage
-2.2x
Debt/Equity
5.88
Current Ratio
4.94
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -3.34x |
| 2026-03-31 | -3.66x |
| 2025-12-31 | -1.10x |
| 2025-09-30 | -1.58x |
| 2025-06-30 | -3.31x |
| 2025-03-31 | -2.39x |
| 2024-12-31 | -1.67x |
| 2024-09-30 | -1.94x |
| 2024-06-30 | -2.88x |
| 2024-03-31 | -3.34x |
| 2023-12-31 | -2.26x |
| 2023-09-30 | -2.72x |
| 2023-06-30 | -3.70x |
| 2023-03-31 | -4.23x |
| 2022-12-31 | -5.08x |
| 2022-09-30 | -5.35x |
| 2022-06-30 | -5.93x |
| 2022-03-31 | -5.33x |
| 2021-12-31 | -4.84x |
| 2021-09-30 | -3.42x |
| 2021-06-30 | -2.46x |
| 2021-03-31 | -2.10x |
| 2020-12-31 | -1.62x |
| 2020-09-30 | -0.42x |
| 2020-06-30 | -0.90x |
| 2020-03-31 | -1.82x |
